March 14th will be a great day for those of you who have been paying $50 – $100 a month for Lexapro. The patent for Lexapro runs out this month, and Mylan pharmaceuticals will launch escitalopram, the first generic equivalent to Lexapro.
Lexapro is a commonly prescribed selective serotonin reuptake inhibitor (SSRI) medication for the acute and maintenance treatment of major depressive disorder in adults and adolescents ages 12 – 17, and for the treatment of generalized anxiety disorder in adults.
Escitalopram, the same medication in generic form, will now be available for the same indications.
Escitalopram will likely be considered a Tier 1 medication by insurance plans, meaning you’ll pay only your lowest co-pay. Lexapro is covered by some insurance plans as a Tier 2 or 3 medication, meaning a higher copay, but this may change with the introduction of the generic option. Lexapro 10 mg tablets can be found for around $100 for a 30-day supply, up to about $150. Escitalopram 10 mg tablets, in contrast, will start at closer to $80 for a 30-day supply.